COVID-19疫苗接种对新冠后心脏并发症的影响
本研究纳入因新冠后评估就诊的患者,排除心脏病患者,分析完成疫苗接种方案(至少两剂且末剂后≥14天)与超声心动图病理性发现及长新冠持续症状的关系。结果显示接种与较低心脏损伤患病率(1.35% vs 4.11%,调整OR 0.33;95%CI 0.17-0.65,p=0.01)和较低持续长新冠症状患病率(10.7% vs 18.3%,调整OR 0.52;95%CI 0.40-0.69,p<0.001)相关。结论认为接种与较低新冠后心脏并发症和症状相关,强调全面接种的重要性。
要点
- 接种组心脏损伤患病率1.35%,未接种组4.11%,调整OR 0.33(95%CI 0.17-0.65,p=0.01)。
- 接种组持续长新冠症状患病率10.7%,未接种组18.3%,调整OR 0.52(95%CI 0.40-0.69,p<0.001)。
- 1883例患者中1070例(56.8%)急性COVID-19时未完成疫苗接种方案。
核心结论
- COVID-19疫苗接种与较低的新冠后心脏并发症和症状患病率相关,强化了全面接种人群的重要性。
研究设计与样本
- 纳入所有因新冠后评估就诊的患者,评估时间为急性疾病出院后14天,排除心脏病患者。
- 采用多变量分析评估完成疫苗接种方案(至少两剂且末剂后≥14天)与超声心动图病理性发现及持续长新冠症状的关系,调整年龄、性别及单变量分析中显示显著差异的临床变量。
主要发现
- 1883例患者中1070例(56.8%)急性COVID-19时未完成疫苗接种方案。
- 接种组心脏损伤患病率1.35%,未接种组4.11%,调整OR 0.33(95%CI 0.17-0.65,p=0.01)。
- 接种组持续长新冠症状患病率10.7%,未接种组18.3%,调整OR 0.52(95%CI 0.40-0.69,p<0.001)。
临床怎么用
- 原文结论未据此给出具体临床推荐,仅指出疫苗接种与较低新冠后心脏并发症和症状相关,并强调全面接种人群的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: After the acute infection, COVID-19 can produce cardiac complications as well as long-COVID persistent symptoms. Although vaccination against COVID-19 represented a clear reduction in both mortality and ICU admissions, there is very little information on whether this was accompanied by a decrease in the prevalence of post-COVID cardiac complications. The aim of this study was to analyze the relationship between COVID-19 vaccination and the prevalence of post-COVID cardiac injury assessed by echocardiogram, and long-COVID persistent cardiac symptoms. METHODS: All patients who consulted for post-COVID evaluation 14 days after discharge from acute illness were included. Patients with heart disease were excluded. The relationship between complete vaccination scheme (at least two doses applied with 14 days or more since the last dose) and pathological echocardiographic findings, as well as the relationship of vaccination with persistent long-COVID symptoms, were evaluated by multivariate analysis, adjusting for age, sex and clinical variables that would have shown significant differences in univariate analysis. RESULTS: From 1883 patients, 1070 patients (56.8%) suffered acute COVID-19 without a complete vaccination scheme. Vaccination was associated with lower prevalence of cardiac injury (1.35% versus 4.11%, adjusted OR 0.33; 95% CI 0.17-0.65, p=0.01). In addition, vaccinated group had a lower prevalence of persistent long-COVID symptoms compared to unvaccinated patients (10.7% versus 18.3%, adjusted OR 0.52; 95% CI 0.40-0.69, p<0.001). CONCLUSION: Vaccination against COVID-19 was associated with lower post-COVID cardiac complications and symptoms, reinforcing the importance of fully vaccinating the population.
引用
- Parodi JB, Indavere A, Bobadilla Jacob P, et al. Impact of COVID-19 vaccination in post-COVID cardiac complications. Vaccine. 2023. PMID: 36725436. doi:10.1016/j.vaccine.2023.01.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。